These data confirm that the three surface proteins LYPD3, TACSTD2, and LY6D are reliable indicators of nuclear MRTF activity as well as prognostic markers of SMOi resistance in human BCC cells. Here, LYPD3 is linked to skin basal cell carcinoma.